SINBIOTIK INTERNACIONAL supplier risk profile Q1 2026: China-focused pharma importer with 96 shipments, 39 suppliers.
SINBIOTIK INTERNACIONAL imported 96 shipments in Q1 2026 across 39 suppliers in 6 countries. China dominated sourcing with 54 shipments (56.3% of total), followed by India with 20 shipments and the United States with 17. The importer's largest supplier was SCRUB DADDY (US, 16 shipments), with WUHAN LIPHARMA CHEMICALS and HUBEI YITAI PHARMACEUTICAL (both China) each contributing 13 shipments. Pharmaceutical active ingredients and precursors (HS Chapter 29) were the primary import category, with HS code 294190 alone representing 14 shipments.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
One name associated with the importer matched a sanctions watchlist during Q1 2026. No suppliers showed direct exposure to forced-labor supply-chain risk under UFLPA frameworks based on the available data.
39 distinct tier-1 suppliers in Q1 2026
| SCRUB DADDY | United States | 16 |
| WUHAN LIPHARMA CHEMICALS | China | 13 |
| HUBEI YITAI PHARMACEUTICAL | China | 13 |
| SHANDONG GUOBANG PHARMACEUTICAL | China | 5 |
| APITORIA PHARMA PRIVATE | India | 4 |
| GN CHEMICALS | China | 3 |
| SHANDONG LUKANG PHARMACEUTICAL | China | 3 |
| FERMENTA BIOTECH | India | 3 |
Share of Q1 2026 inbound shipments by source country
119 tier-2 + 97 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.